One of the WHO’s most important jobs is managing viral outbreaks. The rapid spread of mpox, a disease related to smallpox, is a reminder of its shortcomings.
Although well-intended, the WHO’s overcautious and convoluted regulatory process stalled vaccine delivery for months before an approval was granted last month. Hundreds of lives were lost in the meantime, many of them children.
Mpox, previously called monkeypox, was first discovered in monkeys used for research in 1958. The virus began circulating among humans in western and central Africa more than a decade later. This year, more than 27,000 suspected cases and 800 deaths have been reported in the Democratic Republic of the Congo (DR Congo). A serious outbreak in 2022, which began in Europe and spread to the US, largely subsided last year, although mpox never stopped circulating in the DR Congo.
A new, deadlier and more virulent version of mpox was discovered last year. Like past outbreaks, its symptoms are flu-like and include a rash that can develop into pustules or lesions that cover the body. When these excruciating sores erupt in the mouth and throat, eating can become difficult; some children have died of starvation as a result. Children under 15 make up two-thirds of cases and more than 80 percent of deaths in Africa.
A perfect storm of factors has accelerated the spread of mpox in the DR Congo. Ongoing political violence has displaced millions of people, who have crowded into camps where close contact is difficult to avoid and sex work is common.
Although mpox can spread via sexual contact, it is not considered a sexually transmitted disease.
The country is also battling cholera, malaria and measles.
Public health resources are understandably stretched. Yet the best means of fighting mpox — a safe and effective vaccine, approved by US and European regulators — has been available for years. Why did the WHO take so long to grant its approval and was its separate endorsement necessary?
Low and middle-income countries such as the DR Congo typically depend on UNICEF and global vaccine alliance Gavi to buy and distribute vaccines. Before doing so, the groups must have approval from the WHO, which can either “prequalify” the vaccines — by conducting its own data assessments, inspections and testing — or issue a so-called emergency use listing that would speed access to unlicensed products.
For two years, the WHO took neither path. Despite Congolese officials regularly sharing data with the WHO — and reports that Bavarian Nordic AS, the principal manufacturer, had submitted the research used for its European approval — the organization said it did not have the data required for prequalification.
Meanwhile, an emergency use listing could not be sought until an emergency had been formally declared, which did not happen until August.
Bavarian Nordic, for its part, was left in the dark about procurement commitments from Gavi, which awaited WHO authorization to begin purchase negotiations.
This nest of interdependent approvals would be maddening enough, even if the delays it caused were not so tragic.
The WHO’s instinct to review new data is to some extent understandable. Absent randomized clinical trials, it is hard to assess whether the vaccines approved in Europe and the US are effective against the version of the virus circulating in the DR Congo.
Moreover, giving an unauthorized vaccine to an otherwise healthy population, including children, can be risky. Yet as the virus spreads and the death toll mounts, the benefits of vaccination start to outweigh the potential costs — and the prospect of stalling to replicate lengthy regulatory processes becomes increasingly indefensible.
To its credit, the WHO has stepped up its response over the past month. Vaccine donations from rich countries have started to arrive and, with last month’s announcement, so, too, would purchases from Bavarian Nordic.
Yet the belated resolution must not obscure the need for a nimbler, more straightforward emergency approval process that allows for quick adoption of US and European standards without all the hoops. A similar process has been used successfully for years in Pepfar, the US government program to treat HIV, and should be expanded — if only for the next outbreak. More transparency with manufacturers and other stakeholders throughout the prequalification process would help, too.
The WHO has substantial responsibilities and it should not waste precious time duplicating efforts. By trusting its global partners, it can focus instead on saving lives.
The Editorial Board publishes the views of the editors across a range of national and global affairs.
The EU’s biggest banks have spent years quietly creating a new way to pay that could finally allow customers to ditch their Visa Inc and Mastercard Inc cards — the latest sign that the region is looking to dislodge two of the most valuable financial firms on the planet. Wero, as the project is known, is now rolling out across much of western Europe. Backed by 16 major banks and payment processors including BNP Paribas SA, Deutsche Bank AG and Worldline SA, the platform would eventually allow a German customer to instantly settle up with, say, a hotel in France
On August 6, Ukraine crossed its northeastern border and invaded the Russian region of Kursk. After spending more than two years seeking to oust Russian forces from its own territory, Kiev turned the tables on Moscow. Vladimir Putin seemed thrown off guard. In a televised meeting about the incursion, Putin came across as patently not in control of events. The reasons for the Ukrainian offensive remain unclear. It could be an attempt to wear away at the morale of both Russia’s military and its populace, and to boost morale in Ukraine; to undermine popular and elite confidence in Putin’s rule; to
A traffic accident in Taichung — a city bus on Sept. 22 hit two Tunghai University students on a pedestrian crossing, killing one and injuring the other — has once again brought up the issue of Taiwan being a “living hell for pedestrians” and large vehicle safety to public attention. A deadly traffic accident in Taichung on Dec. 27, 2022, when a city bus hit a foreign national, his Taiwanese wife and their one-year-old son in a stroller on a pedestrian crossing, killing the wife and son, had shocked the public, leading to discussions and traffic law amendments. However, just after the
The international community was shocked when Israel was accused of launching an attack on Lebanon by rigging pagers to explode. Most media reports in Taiwan focused on whether the pagers were produced locally, arousing public concern. However, Taiwanese should also look at the matter from a security and national defense perspective. Lebanon has eschewed technology, partly because of concerns that countries would penetrate its telecommunications networks to steal confidential information or launch cyberattacks. It has largely abandoned smartphones and modern telecommunications systems, replacing them with older and relatively basic communications equipment. However, the incident shows that using older technology alone cannot